Bavarian Nordic Provides 2016 Update

November 12, 2016

Bavarian Nordic, a biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases, this week announced interim financial results for the first three quarters of [Read more]

1 2 3 47